A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
PHASE3
The purpose of study is to compare bladder intact-event free survival (BI-E...
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
PHASE2
Non-small cell lung cancer (NSCLC) is a common type of lung cancer where ab...
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
PHASE3
This study will evaluate safety and tolerability of treatment with atogepan...
Status
Completed
Location
Clinical Research Advantage, Inc./Simon Williamson Clinic, PC